Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment (Nature Communications, (2021), 12, 1, (5086), 10.1038/s41467-021-25177-3)

The NCI PDXNet Consortium

doi:10.1038/s41467-021-27678-7

Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment (Nature Communications, (2021), 12, 1, (5086), 10.1038/s41467-021-25177-3)

The NCI PDXNet Consortium

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

In this Article the Competing interests statement inadvertently omitted a statement for M.T.L. and L.E.D. The competing financial interests for M.T.L. should have read: ‘M.T.L. is a founder and limited partner in StemMed Ltd. and a manager in StemMed Holdings, its general partner. He is a founder and equity stakeholder in Tvardi Theraeutics Inc. Some PDXs are exclusively licensed to StemMed Ltd. resulting in royalty income to M.T.L.’. The competing financial interests for L.E.D. should have read, ‘L.E.D. is a compensated employee of StemMed Ltd’. The PDF and HTML versions of the Article have been corrected.

Original language	English
Article number	294
Journal	Nature communications
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41467-021-27678-7
State	Published - Dec 2022

Access to Document

10.1038/s41467-021-27678-7

Fingerprint

Dive into the research topics of 'Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment (Nature Communications, (2021), 12, 1, (5086), 10.1038/s41467-021-25177-3)'. Together they form a unique fingerprint.

Cite this

@article{8deaad63580c42d8ba7e60eae1a6af57,

title = "Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment (Nature Communications, (2021), 12, 1, (5086), 10.1038/s41467-021-25177-3)",

abstract = "In this Article the Competing interests statement inadvertently omitted a statement for M.T.L. and L.E.D. The competing financial interests for M.T.L. should have read: {\textquoteleft}M.T.L. is a founder and limited partner in StemMed Ltd. and a manager in StemMed Holdings, its general partner. He is a founder and equity stakeholder in Tvardi Theraeutics Inc. Some PDXs are exclusively licensed to StemMed Ltd. resulting in royalty income to M.T.L.{\textquoteright}. The competing financial interests for L.E.D. should have read, {\textquoteleft}L.E.D. is a compensated employee of StemMed Ltd{\textquoteright}. The PDF and HTML versions of the Article have been corrected.",

author = "{The NCI PDXNet Consortium} and Hua Sun and Song Cao and Mashl, {R. Jay} and Mo, {Chia Kuei} and Simone Zaccaria and Wendl, {Michael C.} and Davies, {Sherri R.} and Bailey, {Matthew H.} and Primeau, {Tina M.} and Jeremy Hoog and Mudd, {Jacqueline L.} and Dean, {Dennis A.} and Rajesh Patidar and Li Chen and Wyczalkowski, {Matthew A.} and Jayasinghe, {Reyka G.} and Rodrigues, {Fernanda Martins} and Terekhanova, {Nadezhda V.} and Yize Li and Lim, {Kian Huat} and Andrea Wang-Gillam and {Van Tine}, {Brian A.} and Ma, {Cynthia X.} and Rebecca Aft and Fuh, {Katherine C.} and Schwarz, {Julie K.} and Zevallos, {Jose P.} and Puram, {Sidharth V.} and Dipersio, {John F.} and Julie Belmar and Jason Held and Jingqin Luo and {Van Tine}, {Brian A.} and Rose Tipton and Yige Wu and Lijun Yao and Zhou, {Daniel Cui} and Andrew Butterfield and Zhengtao Chu and Maihi Fujita and Yang, {Chieh Hsiang} and Emilio Cortes-Sanchez and Sandra Scherer and Ling Zhao and Tijana Borovski and Vicki Chin and John DiGiovanna and Christian Frech and Jeffrey Grover and Ryan Jeon and Soner Koc and Jelena Randjelovic and Sara Seepo and Tamara Stankovic and Dobrolecki, {Lacey E.} and Michael Ittmann and Hilsenbeck, {Susan G.} and O{\textquoteright}Malley, {Bert W.} and Nicholas Mitsiades and Salma Kaochar and Argun Akcakanat and Jithesh Augustine and Huiqin Chen and Bingbing Dai and Evans, {Kurt W.} and Kelly Gale and Don Gibbons and Ha, {Min Jin} and Vanessa Jensen and Michael Kim and Kirby, {Bryce P.} and Scott Kopetz and Lanier, {Christopher D.} and Dali Li and Mourad Majidi and David Menter and Ismail Meraz and Turcin Saridogan and Stephen Scott and Alexey Sorokin and Coya Tapia and Jing Wang and Shannon Westin and Yuanxin Xi and Yi Xu and Fei Yang and Yap, {Timothy A.} and Yennu-Nanda, {Vashisht G.} and Erkan Yuca and Jianhua Zhang and Ran Zhang and Xiaoshan Zhang and Xiaofeng Zheng and Dylan Fingerman and Haiyin Lin and Qin Liu and Kossenkov, {Andrew V.} and Rebecca, {Vito W.} and Rajasekharan Somasundaram and Tetzlaff, {Michae T.} and Jayamanna Wickramasinghe and Min Xiao and Xiaowei Xu and Bult, {Carol J.} and Robinson, {Peter N.} and Anuj Srivastava and Lloyd, {Michael W.} and Neuhauser, {Steven B.} and Jill Rubinstein and Sanderson, {Brian J.} and Brian White and Woo, {Xing Yi} and Tiffany Wallace and Minna, {John D.} and Gao Boning and Luc Girard and Hyunsil Park and Timmons, {Brenda C.} and Nathanson, {Katherine L.} and George Xu and Pan, {Chong xian} and Chen, {Moon S.} and Carvajal-Carmona, {Luis G.} and May Cho and Coggins, {Nicole B.} and White, {Ralph W.de Vere} and Guadalupe Polanco-Echeverry and Ana Estrada and Gandara, {David R.} and Kirane, {Amanda R.} and Tiffany Le and Paul Lott and Arana, {Alexa Morales} and Reiss, {Jonathan W.} and Sienna Rocha and Tepper, {Clifford G.} and Ted Toal and Hongyong Zhang and Ma, {Ai Hong} and Brandi Davis-Dusenbery and Ellis, {Matthew J.} and Lewis, {Michael T.} and Davies, {Michael A.} and Meenhard Herlyn and Bingliang Fang and Roth, {Jack A.} and Welm, {Alana L.} and Welm, {Bryan E.} and Funda Meric-Bernstam and Feng Chen and Fields, {Ryan C.} and Shunqiang Li and Ramaswamy Govindan and Doroshow, {James H.} and Moscow, {Jeffrey A.} and Evrard, {Yvonne A.} and Chuang, {Jeffrey H.} and Raphael, {Benjamin J.} and Li Ding",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1038/s41467-021-27678-7",

language = "English",

volume = "13",

journal = "Nature communications",

issn = "2041-1723",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment (Nature Communications, (2021), 12, 1, (5086), 10.1038/s41467-021-25177-3)

AU - The NCI PDXNet Consortium

AU - Sun, Hua

AU - Cao, Song

AU - Mashl, R. Jay

AU - Mo, Chia Kuei

AU - Zaccaria, Simone

AU - Wendl, Michael C.

AU - Davies, Sherri R.

AU - Bailey, Matthew H.

AU - Primeau, Tina M.

AU - Hoog, Jeremy

AU - Mudd, Jacqueline L.

AU - Dean, Dennis A.

AU - Patidar, Rajesh

AU - Chen, Li

AU - Wyczalkowski, Matthew A.

AU - Jayasinghe, Reyka G.

AU - Rodrigues, Fernanda Martins

AU - Terekhanova, Nadezhda V.

AU - Li, Yize

AU - Lim, Kian Huat

AU - Wang-Gillam, Andrea

AU - Van Tine, Brian A.

AU - Ma, Cynthia X.

AU - Aft, Rebecca

AU - Fuh, Katherine C.

AU - Schwarz, Julie K.

AU - Zevallos, Jose P.

AU - Puram, Sidharth V.

AU - Dipersio, John F.

AU - Belmar, Julie

AU - Held, Jason

AU - Luo, Jingqin

AU - Van Tine, Brian A.

AU - Tipton, Rose

AU - Wu, Yige

AU - Yao, Lijun

AU - Zhou, Daniel Cui

AU - Butterfield, Andrew

AU - Chu, Zhengtao

AU - Fujita, Maihi

AU - Yang, Chieh Hsiang

AU - Cortes-Sanchez, Emilio

AU - Scherer, Sandra

AU - Zhao, Ling

AU - Borovski, Tijana

AU - Chin, Vicki

AU - DiGiovanna, John

AU - Frech, Christian

AU - Grover, Jeffrey

AU - Jeon, Ryan

AU - Koc, Soner

AU - Randjelovic, Jelena

AU - Seepo, Sara

AU - Stankovic, Tamara

AU - Dobrolecki, Lacey E.

AU - Ittmann, Michael

AU - Hilsenbeck, Susan G.

AU - O’Malley, Bert W.

AU - Mitsiades, Nicholas

AU - Kaochar, Salma

AU - Akcakanat, Argun

AU - Augustine, Jithesh

AU - Chen, Huiqin

AU - Dai, Bingbing

AU - Evans, Kurt W.

AU - Gale, Kelly

AU - Gibbons, Don

AU - Ha, Min Jin

AU - Jensen, Vanessa

AU - Kim, Michael

AU - Kirby, Bryce P.

AU - Kopetz, Scott

AU - Lanier, Christopher D.

AU - Li, Dali

AU - Majidi, Mourad

AU - Menter, David

AU - Meraz, Ismail

AU - Saridogan, Turcin

AU - Scott, Stephen

AU - Sorokin, Alexey

AU - Tapia, Coya

AU - Wang, Jing

AU - Westin, Shannon

AU - Xi, Yuanxin

AU - Xu, Yi

AU - Yang, Fei

AU - Yap, Timothy A.

AU - Yennu-Nanda, Vashisht G.

AU - Yuca, Erkan

AU - Zhang, Jianhua

AU - Zhang, Ran

AU - Zhang, Xiaoshan

AU - Zheng, Xiaofeng

AU - Fingerman, Dylan

AU - Lin, Haiyin

AU - Liu, Qin

AU - Kossenkov, Andrew V.

AU - Rebecca, Vito W.

AU - Somasundaram, Rajasekharan

AU - Tetzlaff, Michae T.

AU - Wickramasinghe, Jayamanna

AU - Xiao, Min

AU - Xu, Xiaowei

AU - Bult, Carol J.

AU - Robinson, Peter N.

AU - Srivastava, Anuj

AU - Lloyd, Michael W.

AU - Neuhauser, Steven B.

AU - Rubinstein, Jill

AU - Sanderson, Brian J.

AU - White, Brian

AU - Woo, Xing Yi

AU - Wallace, Tiffany

AU - Minna, John D.

AU - Boning, Gao

AU - Girard, Luc

AU - Park, Hyunsil

AU - Timmons, Brenda C.

AU - Nathanson, Katherine L.

AU - Xu, George

AU - Pan, Chong xian

AU - Chen, Moon S.

AU - Carvajal-Carmona, Luis G.

AU - Cho, May

AU - Coggins, Nicole B.

AU - White, Ralph W.de Vere

AU - Polanco-Echeverry, Guadalupe

AU - Estrada, Ana

AU - Gandara, David R.

AU - Kirane, Amanda R.

AU - Le, Tiffany

AU - Lott, Paul

AU - Arana, Alexa Morales

AU - Reiss, Jonathan W.

AU - Rocha, Sienna

AU - Tepper, Clifford G.

AU - Toal, Ted

AU - Zhang, Hongyong

AU - Ma, Ai Hong

AU - Davis-Dusenbery, Brandi

AU - Ellis, Matthew J.

AU - Lewis, Michael T.

AU - Davies, Michael A.

AU - Herlyn, Meenhard

AU - Fang, Bingliang

AU - Roth, Jack A.

AU - Welm, Alana L.

AU - Welm, Bryan E.

AU - Meric-Bernstam, Funda

AU - Chen, Feng

AU - Fields, Ryan C.

AU - Li, Shunqiang

AU - Govindan, Ramaswamy

AU - Doroshow, James H.

AU - Moscow, Jeffrey A.

AU - Evrard, Yvonne A.

AU - Chuang, Jeffrey H.

AU - Raphael, Benjamin J.

AU - Ding, Li

PY - 2022/12

Y1 - 2022/12

N2 - In this Article the Competing interests statement inadvertently omitted a statement for M.T.L. and L.E.D. The competing financial interests for M.T.L. should have read: ‘M.T.L. is a founder and limited partner in StemMed Ltd. and a manager in StemMed Holdings, its general partner. He is a founder and equity stakeholder in Tvardi Theraeutics Inc. Some PDXs are exclusively licensed to StemMed Ltd. resulting in royalty income to M.T.L.’. The competing financial interests for L.E.D. should have read, ‘L.E.D. is a compensated employee of StemMed Ltd’. The PDF and HTML versions of the Article have been corrected.

AB - In this Article the Competing interests statement inadvertently omitted a statement for M.T.L. and L.E.D. The competing financial interests for M.T.L. should have read: ‘M.T.L. is a founder and limited partner in StemMed Ltd. and a manager in StemMed Holdings, its general partner. He is a founder and equity stakeholder in Tvardi Theraeutics Inc. Some PDXs are exclusively licensed to StemMed Ltd. resulting in royalty income to M.T.L.’. The competing financial interests for L.E.D. should have read, ‘L.E.D. is a compensated employee of StemMed Ltd’. The PDF and HTML versions of the Article have been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85122762782&partnerID=8YFLogxK

U2 - 10.1038/s41467-021-27678-7

DO - 10.1038/s41467-021-27678-7

M3 - Comment/debate

C2 - 34996889

AN - SCOPUS:85122762782

SN - 2041-1723

VL - 13

JO - Nature communications

JF - Nature communications

IS - 1

M1 - 294

ER -

Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment (Nature Communications, (2021), 12, 1, (5086), 10.1038/s41467-021-25177-3)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this